Arthralgia During Anastrozole Therapy for Breast Cancer

• Status: Completed
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to describe the joint symptoms and structural joint changes under anastrozole as adjuvant treatment in postmenopausal women with early breast cancer.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Anastrozole

Criteria

Inclusion Criteria:

• Post menopausal woman with a breast cancer and scheduled for an adjuvant treatment with anastrozole

• WHO performance status 0, 1 or 2

• Provision of written informed consent

Exclusion Criteria:

• Recurrence of breast cancer, inflammatory rheumatism

• treatment by chondromodulator, oral glucocorticoid, aromatase inhibitor, anti estrogen, Herceptin

• Diabetes treated by insulin

• Severe renal or hepatic disease

• Known hypersensitivity to anastrozole